Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Vaccine|October 16, 2013
Safety and immunogenicity of a plant-produced recombinant monomer hemagglutinin-based influenza vaccine derived from influenza A (H1N1)pdm09 virus: a Phase 1 dose-escalation study in healthy adultsJames F Cummings, Melanie L Guerrero, James E Moon, et al.
Vaccine|April 29, 2008
Plant-expressed HA as a seasonal influenza vaccine candidateYoko Shoji, Jessica A Chichester, Hong Bi, et al.
Molecular and Cellular Probes|April 1, 2022
An ELISA-based antigenicity test of rabies recombinant glycoprotein cannot predict its protective potency in vivoDmitriy V Volokhov, Alethea M Fry, Vyacheslav Furtak, et al.
Plos One|August 23, 2013
Functional testing of an inhalable nanoparticle based influenza vaccine using a human precision cut lung slice techniqueVanessa Neuhaus, Katharina Schwarz, Anna Klee, et al.
Human Vaccines|September 20, 2011
An influenza N1 neuraminidase-specific monoclonal antibody with broad neuraminidase inhibition activity against H5N1 HPAI virusesYoko Shoji, Jessica A Chichester, Gene A Palmer, et al.
Human Vaccines|January 27, 2011
Plant-based rapid production of recombinant subunit hemagglutinin vaccines targeting H1N1 and H5N1 influenzaYoko Shoji, Jessica A Chichester, Mark Jones, et al.
Vaccine|February 10, 2009
Immunogenicity of hemagglutinin from A/Bar-headed Goose/Qinghai/1A/05 and A/Anhui/1/05 strains of H5N1 influenza viruses produced in Nicotiana benthamiana plantsYoko Shoji, Christine E Farrance, Hong Bi, et al.
Proteomics|May 12, 2012
Comparative characterization of the glycosylation profiles of an influenza hemagglutinin produced in plant and insect hostsSheng Zhang, Robert W Sherwood, Yong Yang, et al.
Human Vaccines|January 29, 2011
A non-glycosylated, plant-produced human monoclonal antibody against anthrax protective antigen protects mice and non-human primates from B. anthracis spore challengeVadim Mett, Jessica A Chichester, Michelle L Stewart, et al.
Vaccine|August 22, 2018
Safety and immunogenicity of a plant-produced Pfs25 virus-like particle as a transmission blocking vaccine against malaria: A Phase 1 dose-escalation study in healthy adultsJessica A Chichester, Brian J Green, R Mark Jones, et al.
Pageof 9